{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:14:01Z","timestamp":1790356441600,"version":"4.1.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Japanese encephalitis virus (JEV) and Zika virus (ZIKV) are prevalent in over 80 countries or territories worldwide, causing hundreds of thousands of cases annually. But currently there is a lack of specific antiviral agents and effective vaccines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In the present study, to identify human neutralizing monoclonal antibody (mAb) against JEV or\/and ZIKV, we isolated ZIKV-E protein-binding B cells from the peripheral venous blood of a healthy volunteer who had received the JEV live-attenuated vaccine and performed 10\u00d7 Genomics transcriptome sequencing and BCR sequencing analysis, we then obtained the V region amino acid sequences of a novel mAb LZY3412. We expressed mAb LZY3412 and evaluated its ability to bind to E proteins of dengue virus, JEV and ZIKV, neutralize JEV and ZIKV infections <jats:italic>in vitro<\/jats:italic>, protect mice against lethal JEV or ZIKV attack. The epitopes on E proteins of JEV\/ZIKV recognized by mAb LZY3412 were analyzed using molecular docking and constructing E protein mutants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results show that recombinant mAb LZY3412 has high-affinity with the E proteins of three viruses, with the kinetically derived binding affinity (KD) values of 440 and 482.5 nM against JEV-E protein and ZIKV-E protein, respectively; recombinant mAb LZY3412 can efficiently neutralize JEV and ZIKV infections <jats:italic>in vitro<\/jats:italic>, with the NT<jats:sub>50<\/jats:sub> values of 19.9 ng\/mL and 631 ng\/mL, respectively; application of recombinant mAb LZY3412 can significantly improve the percentage survival and reduce the serum viral loads of neonatal mice infected with JEV or ZIKV. Finally, two amino acid residues (Ala399 and Gly400) located in EDIII of JEV-E protein were potentially recognized by LZY3412 whereas two amino acid residues (Met15 and Thr406) out of EDIII of ZIKV-E proteins were recognized by LZY3412.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Considering mAb LZY3412 has neutralizing effects on various flaviviruses, this mAb is expected to be developed as therapeutic or preventive drug for these flaviviruses, and can also be used to guide the development of vaccines against these flaviviruses.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2024.1508923","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:54:25Z","timestamp":1734954865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["A human monoclonal antibody isolated from Japanese encephalitis virus vaccine-vaccinated volunteer neutralizing various flaviviruses"],"prefix":"10.3389","volume":"15","author":[{"given":"Dong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsheng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e1010814","DOI":"10.1371\/journal.ppat.1010814","article-title":"Structure and neutralization mechanism of a human antibody targeting a complex epitope on Zika virus","volume":"19","author":"Adams","year":"2023","journal-title":"PLoS Pathog."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e00405-19","DOI":"10.1128\/JVI.00405-19","article-title":"Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein","volume":"93","author":"Bailey","year":"2019","journal-title":"J. Virol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4269\/ajtmh.19-0073","article-title":"A monoclonal antibody specific for Japanese encephalitis virus with high neutralizing capability for inclusion as a positive control in diagnostic neutralization tests","volume":"101","author":"Calvert","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/mBio.00008-18","article-title":"Japanese encephalitis surveillance and immunization\u2014Asia and the Western Pacific, 2012","volume":"62","year":"2013","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e20192152","DOI":"10.1084\/jem.20192152","article-title":"Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis","volume":"217","author":"Chen","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes","volume":"4","author":"Collins","year":"2019","journal-title":"JCI Insight"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a Flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","article-title":"A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus","volume":"16","author":"Dejnirattisai","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e16059","DOI":"10.1371\/journal.pone.0016059","article-title":"A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein","volume":"6","author":"Deng","year":"2011","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.drudis.2021.10.013","article-title":"Docking and scoring for nucleic acid-ligand interactions: principles and current status","volume":"27","author":"Feng","year":"2022","journal-title":"Drug Discov. Today"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1021\/acs.jcim.1c00341","article-title":"NLDock: a fast nucleic acid-ligand docking algorithm for modeling RNA\/DNA-ligand complexes","volume":"61","author":"Feng","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e00008","DOI":"10.1128\/mBio.00008-18","article-title":"Mouse and human monoclonal antibodies protect against infection by multiple genotypes of Japanese encephalitis virus","volume":"9","author":"Fernandez","year":"2018","journal-title":"MBio"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.micinf.2019.04.005","article-title":"Zika virus infection: an update","volume":"21","author":"Ferraris","year":"2019","journal-title":"Microbes Infect."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.antiviral.2016.01.002","article-title":"The development of therapeutic antibodies against dengue virus","volume":"128","author":"Fibriansah","year":"2016","journal-title":"Antivir. Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.3390\/ijms23147805","article-title":"New anti-flavivirus fusion loop human antibodies with Zika virus-neutralizing potential","volume":"23","author":"Franca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1371\/journal.pntd.0003015","article-title":"Vaccine strategies for the control and prevention of Japanese encephalitis in mainland China, 1951-2011","volume":"8","author":"Gao","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"7009","DOI":"10.1128\/JVI.00291-08","article-title":"Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo","volume":"82","author":"Goncalvez","year":"2008","journal-title":"J. Virol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e02420","DOI":"10.1128\/JVI.02423-20","article-title":"A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies","volume":"95","author":"Graham","year":"2021","journal-title":"J. Virol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"14722","DOI":"10.1038\/ncomms14722","article-title":"A human antibody against Zika virus crosslinks the E protein to prevent infection","volume":"8","author":"Hasan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","article-title":"A combination of two human monoclonal antibodies prevents Zika virus escape mutations in non-human Primates","volume":"25","author":"Keeffe","year":"2018","journal-title":"Cell Rep."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3389\/fmicb.2018.02126","article-title":"History of ZIKV infections in India and Management of Disease Outbreaks","volume":"9","author":"Khaiboullina","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1128\/JVI.72.1.73-83.1998","article-title":"Phylogeny of the genus Flavivirus","volume":"72","author":"Kuno","year":"1998","journal-title":"J. Virol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"20683","DOI":"10.2807\/1560-7917.ES2014.19.4.20683","article-title":"Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014","volume":"19","author":"Kutsuna","year":"2014","journal-title":"Euro Surveill."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2016.04.017","article-title":"Zika virus disrupts neural progenitor development and leads to microcephaly in mice","volume":"19","author":"Li","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1073\/pnas.1815432116","article-title":"Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope","volume":"116","author":"Long","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"8184","DOI":"10.1126\/scitranslmed.aan8184","article-title":"Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques","volume":"9","author":"Magnani","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.autrev.2017.10.008","article-title":"Zika virus and autoimmunity. One-step forward","volume":"16","author":"Monsalve","year":"2017","journal-title":"Autoimmun Rev"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1080\/22221751.2019.1614885","article-title":"Convalescent patient-derived monoclonal antibodies targeting different epitopes of E protein confer protection against Zika virus in a neonatal mouse model","volume":"8","author":"Niu","year":"2019","journal-title":"Emerg. Microbes Infect"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2018.04.011","article-title":"Human monoclonal antibodies against West Nile virus from Japanese encephalitis-vaccinated volunteers","volume":"154","author":"Ozawa","year":"2018","journal-title":"Antivir. Res."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41564-017-0099-x","article-title":"Structural basis for neutralization of Japanese encephalitis virus by two potent therapeutic antibodies","volume":"3","author":"Qiu","year":"2018","journal-title":"Nat. Microbiol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4269\/ajtmh.16-0979","article-title":"Chikungunya and Zika virus cases detected against a backdrop of endemic dengue transmission in Vietnam","volume":"97","author":"Quyen","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico","volume":"169","author":"Robbiani","year":"2017","journal-title":"Cell"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.tim.2011.02.002","article-title":"Partial maturation: an immune-evasion strategy of dengue virus?","volume":"19","author":"Rodenhuis-Zybert","year":"2011","journal-title":"Trends Microbiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1473-3099(18)30718-7","article-title":"Long-term circulation of Zika virus in Thailand: an observational study","volume":"19","author":"Ruchusatsawat","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.26633\/RPSP.2023.34","article-title":"Dengue, chikungunya, and Zika virus infections in Latin America and the Caribbean: a systematic review","volume":"47","author":"Santos","year":"2023","journal-title":"Rev. Panam. Salud Publica"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/v12121346","article-title":"Structural basis of Zika virus specific neutralization in subsequent Flavivirus infections","volume":"12","author":"Sevvana","year":"2020","journal-title":"Viruses"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 a resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2017.09.002","article-title":"A human Bi-specific antibody against Zika virus with high therapeutic potential","volume":"171","author":"Wang","year":"2017","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"6779","DOI":"10.1007\/s00253-020-10710-z","article-title":"T cell immunity rather than antibody mediates cross-protection against Zika virus infection conferred by a live attenuated Japanese encephalitis SA14-14-2 vaccine","volume":"104","author":"Wang","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref52","volume-title":"WHO Situation Report - Zika Virus, Microcephaly, Guillain-Barr\u00e9 Syndrome","year":"2016"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1172\/jci.insight.93042","article-title":"Delineating antibody recognition against Zika virus during natural infection","volume":"2","author":"Yu","year":"2017","journal-title":"JCI Insight"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13238-016-0274-5","article-title":"Highly diversified Zika viruses imported to China, 2016","volume":"7","author":"Zhang","year":"2016","journal-title":"Protein Cell"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.celrep.2020.107584","article-title":"A human antibody neutralizes different Flaviviruses by using different mechanisms","volume":"31","author":"Zhang","year":"2020","journal-title":"Cell Rep."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jmv.1890290211","article-title":"Passive protection of mice, goats, and monkeys against Japanese encephalitis with monoclonal antibodies","volume":"29","author":"Zhang","year":"1989","journal-title":"J. Med. Virol."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1084\/jem.20191792","article-title":"Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge","volume":"217","author":"Zhao","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1508923\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T11:54:29Z","timestamp":1734954869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2024.1508923\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":55,"alternative-id":["10.3389\/fmicb.2024.1508923"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2024.1508923","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"article-number":"1508923"}}